Responding to the rofecoxib withdrawal crisis: a new model for notifying patients at risk and their health care providers

scientific article

Responding to the rofecoxib withdrawal crisis: a new model for notifying patients at risk and their health care providers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7326/0003-4819-142-3-200502010-00008
P698PubMed publication ID15684206

P2093author name stringJames Young
Anil Jain
C Martin Harris
Ashish Atreja
Jon Burns
Meghan Lehmann
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)182-186
P577publication date2005-02-01
P1433published inAnnals of Internal MedicineQ564416
P1476titleResponding to the rofecoxib withdrawal crisis: a new model for notifying patients at risk and their health care providers
P478volume142

Reverse relations

cites work (P2860)
Q37389352Ability to generate patient registries among practices with and without electronic health records
Q38429530Benchmarking electronic medical records initiatives in the US: a conceptual model
Q48545409Currents in contemporary bioethics: physicians' duty to inform patients of new medical discoveries: the effect of health information technology
Q34293754Effect of a clinical trial alert system on physician participation in trial recruitment
Q36608310Health information technology will shift the medical care paradigm
Q34663541Primary Care Management of Chronic Kidney Disease
Q36059964Responding rapidly to FDA drug withdrawals: design and application of a new approach for a consumer health website
Q36539351Reviewing the benefits and costs of electronic health records and associated patient safety technologies
Q39241785Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.